Clobazam
- Product NDC
- 51672-4210
- 11-digit product format
- 516724210
- Labeler code
- 51672
- Product ID
- 51672-4210_42e2146c-a750-4c71-b6be-b1101c662454
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- clobazam
- Dosage form
- SUSPENSION
- Route
- ORAL
- Labeler
- Taro Pharmaceuticals U.S.A., Inc.
- Application
- ANDA210978
- Marketing category
- ANDA
- Marketing start
- 2019-04-16
- Marketing end
- 0000-00-00
- Substance
- CLOBAZAM
- Active strength
- 3 mg/mL
- Pharmacologic classes
- Benzodiazepine [EPC],Benzodiazepines [CS],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 3A4 Inducers [MoA]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 51672-4210-8 | 51672421008 | 1 BOTTLE in 1 CARTON (51672-4210-8) > 120 mL in 1 BOTTLE | 1 bottle | 2019-04-16 | 0000-00-00 | No | No | Current |